Changing a supply chain is easier said than done
May 22, 2019

Changing a supply chain is easier said than done

Plus: how Qualcomm's antitrust case could affect 5G, and a conversation with the creators of "The Marvelous Mrs. Maisel."

Segments From this episode

New gene therapy drug expected to hit market with head-spinning price tag

May 22, 2019
Industry analysts expect the price for the single-treatment therapy to be anywhere from $1.5 million to $5 million.
Swiss pharmaceutical giant Novartis' Basel headquarters.

Changing supply chains isn't as easy as 1, 2, 3

May 22, 2019
Some companies are better suited to change where they get things made than others.

Is it time for U.S. businesses to rethink their Chinese partnerships?

May 22, 2019
Democratic Senator Mark Warner has been urging American executives to reflect on the risks.
An investor reads a newspaper in front of screens showing stock market movements at a securities company in Beijing on May 14, 2019.
WANG ZHAO/AFP/Getty Images

Music from the episode

The team

Nancy Farghalli Executive Producer
Bridget Bodnar Producer
Daisy Palacios Producer
Sean McHenry Associate Producer
Maria Hollenhorst Associate Producer